London, UK. 21st Nov, 2017. A press briefing by Guido Rasi, Executive Director of EMA and Noel Whation Deputy Executive Director of EMA European Medecines Agency who addressed the media after the anouncement to relocate to Amsterdam was taken by 27 EU member states which was influenced by Brexit and the decision of the United Kingdom to leave the European Union. Credit: amer ghazzal/Alamy Live News Credit: amer ghazzal/Alamy Live News
London UK. 21st November 2017. A press briefing by Guido Rasi ,Executive Director of EMA and Noel Whation Deputy Executive Director of EMA European Medecines Agency who addressed the media after the anouncement to relocate to Amsterdam was taken by 27 EU member states which was influenced by Brexit and the decision of the United Kingdom to leave the European Union. The EMA he European Medecines Agency which helps national authorities authorise the sale of drugs across the EU's single market of some 500 million people has has been based at Canary Wharf in east London since 1995 and has about 900 staff
Size: 1984px × 2976px
Photo credit: © amer ghazzal / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 2017, agency, britain, coronavirus, covid, covid-19, ema, epidemic, eu, europe, european, health, healthcare, london, medicine, medicines, pandemic, pharmaceutical, pharmacy, science, supply, uk, union, vaccination, vaccine, virus
